Global Infusion/Medical Pumps Market to Reach USD 6.7 Billion in 2012, Forecasts Kalorama Information
13 Nov 2012 • by Natalie Aster
The worldwide market for infusion/medical pumps will show continued growth this year, increasing to $6.7 billion in 2012. The healthcare market research publisher estimated likely 2012 sales based on results so far this year and last year's results, as well as interviews with infusion pump makers. Aging world populations, expanding global markets, and new product innovations have driven an average annual growth rate of 3.6% since 2007, according to the report “The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)” by Kalorama Information.
The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
Published: November, 2012
Price: US$ 3.995,00
Infusion pumps are used to infuse necessary fluids, which include medications and/or nutrients, to a patient’s circulatory system. They are often used in situations where continuous monitoring and treatment by a nurse or other health staff would be expensive, impractical, or unreliable. They are used for everything from very simple requirements such as rehydration to more complex requirements such as those needed for chemotherapy and pain management. Accuracy and consistency when delivering medications and other fluids are essential due to the possibility of severe consequences.
More than 100 companies participate in the infusion pump market. These include well-known companies such as Abbott, Medtronic, Fresenius, CareFusion, Johnson & Johnson (Animas) and Baxter. However, a number of companies specialize in certain areas. Among these companies are Insulet whose OmniPod delivers insulin without tubing, MRI safe pumps from IRadimed, enteral feeding pumps from Moog and I-Flow home care pumps.
"It's possible for these innovative small players to cede general market leadership to the big players and still participate with intense market efforts in a narrow segment," said Melissa Elder, Kalorama analyst and author of the report. "This is a growing market and new entrants and innovators should be expected as disease incidence unfortunately grows."
There are challenges to the market, health risks to infusion pumps and recent recalls. Still, Kalorama Information expects revenue for existing and new competitors in the market to grow with increased demand and new emerging markets spending on healthcare.
More information can be found in the report “The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)” by Kalorama Information.
To order the report or ask for sample pages contact [email protected]